Related Experiment Video
Updated: Jan 5, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
Anna Maria Malfitano1, Sarah Di Somma2, Nella Prevete3
1Dipartimento di Scienze Mediche Traslazionali, Università Federico II Napoli, URT "Genomic of Diabetes" of Institute of Experimental Endocrinology and Oncology "G. Salvatore", National Council of Research (CNR), 80131 Naples, Italy. annamaria.malfitano@unina.it.
Abstract:
Virotherapy is a novel cancer treatment based on oncolytic viruses (OVs), which selectively infect and lyse cancer cells, without harming normal cells or tissues. Several viruses, either naturally occurring or developed through genetic engineering, are currently under investigation in clinical studies. Emerging reports suggesting the immune-stimulatory property of OVs against tumor cells further support the clinical use of OVs for the treatment of lesions lacking effective therapies. Poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC), have a poor prognosis and limited treatment options. Therefore, several groups investigated the therapeutic potential of OVs in PDTC/ATC models producing experimental data sustaining the potential clinical efficacy of OVs in these cancer models. Moreover, the presence of an immunosuppressive microenvironment further supports the potential use of OVs in ATC. In this review, we present the results of the studies evaluating the efficacy of OVs alone or in combination with other treatment options. In particular, their potential therapeutic combination with multiple kinases inhibitors (MKIs) or immune checkpoint inhibitors are discussed.
Insights
Oncolytic viruses (OVs) show promise for treating aggressive thyroid cancers like PDTC and ATC. Research explores OVs alone or combined with other therapies, offering new hope for patients with limited options.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Virotherapy utilizes oncolytic viruses (OVs) to selectively target and destroy cancer cells.
- OVs possess immune-stimulatory properties beneficial for cancer treatment.
- Poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC) present significant therapeutic challenges.
Purpose of the Study:
- To review the therapeutic potential of OVs in PDTC and ATC models.
- To evaluate the efficacy of OVs as monotherapy and in combination treatments.
- To discuss the role of OVs in overcoming the immunosuppressive tumor microenvironment.
Main Methods:
- Review of existing experimental data on OV efficacy in PDTC/ATC models.
- Analysis of studies combining OVs with other therapeutic agents.
- Investigation of OV mechanisms in modulating the tumor microenvironment.
Main Results:
- Experimental data support the clinical efficacy of OVs in PDTC/ATC models.
- OVs demonstrate potential in overcoming the immunosuppressive nature of ATC.
- Combinatorial strategies involving OVs show promise for enhanced therapeutic outcomes.
Conclusions:
- Oncolytic virotherapy is a promising approach for treating aggressive thyroid cancers.
- Combination therapies, particularly with multiple kinases inhibitors (MKIs) or immune checkpoint inhibitors, warrant further investigation.
- OVs offer a potential new avenue for managing difficult-to-treat thyroid malignancies.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

